# Nuo Therapeutics, Inc.: Form 8-K, filed Aug 30, 2022

- Company: [Nuo Therapeutics, Inc.](/companies/aurx.md) (CIK 1091596)
- Form: 8-K
- Filed: 2022-08-30
- Accepted by EDGAR: Aug 30, 2022, 12:15 ET
- Period: 2022-08-24
- Accession: 0001437749-22-021470
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1091596/000143774922021470/aurx20220824b_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1091596/000143774922021470/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1091596/000143774922021470/aurx20220824b_8k.htm

Filed Aug 30, 2022.
Source: SEC EDGAR, the filing index for accession 0001437749-22-021470. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.